BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 34590434)

  • 1. 2,3-Dihydroquinazolin-4(1
    O'Brien NS; Gilbert J; McCluskey A; Sakoff JA
    RSC Med Chem; 2024 May; 15(5):1686-1708. PubMed ID: 38784470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diselenides and Benzisoselenazolones as Antiproliferative Agents and Glutathione-S-Transferase Inhibitors.
    Krasowska D; Iraci N; Santi C; Drabowicz J; Cieslak M; Kaźmierczak-Barańska J; Palomba M; Królewska-Golińska K; Magiera J; Sancineto L
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31405214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amperometric measurements at cells support a role for dynamin in the dilation of the fusion pore during exocytosis.
    Trouillon R; Ewing AG
    Chemphyschem; 2013 Jul; 14(10):2295-301. PubMed ID: 23824748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the bioactivity of novel spiroisoxazoline typecompounds against normal and cancer cell lines.
    Najim N; Bathich Y; Zain MM; Hamzah AS; Shaameri Z
    Molecules; 2010 Dec; 15(12):9340-53. PubMed ID: 21169884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino alcohol acrylonitriles as broad spectrum and tumour selective cytotoxic agents.
    Baker JR; Russell CC; Gilbert J; McCluskey A; Sakoff JA
    RSC Med Chem; 2021 Jun; 12(6):929-942. PubMed ID: 34263170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sulfonadyns: a class of aryl sulfonamides inhibiting dynamin I GTPase and clathrin mediated endocytosis are anti-seizure in animal models.
    Odell LR; Jones NC; Chau N; Robertson MJ; Ambrus JI; Deane FM; Young KA; Whiting A; Xue J; Prichard K; Daniel JA; Gorgani NN; O'Brien TJ; Robinson PJ; McCluskey A
    RSC Med Chem; 2023 Aug; 14(8):1492-1511. PubMed ID: 37593570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study.
    AboulWafa OM; Daabees HMG; Badawi WA
    Bioorg Chem; 2020 Jun; 99():103798. PubMed ID: 32247112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,5-Bis(trifluoromethyl)phenylsulfonamides, a novel pancreatic cancer active lead. Investigation of the terminal aromatic moiety.
    Sun J; Ambrus JI; Baker JR; Russell CC; Cossar PJ; Sakoff JA; Scarlett CJ; McCluskey A
    Bioorg Med Chem Lett; 2022 Apr; 61():128591. PubMed ID: 35114371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues.
    Hizartzidis L; Gilbert J; Gordon CP; Sakoff JA; McCluskey A
    ChemMedChem; 2019 Jun; 14(12):1152-1161. PubMed ID: 30938091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dichlorophenylacrylonitriles as AhR Ligands That Display Selective Breast Cancer Cytotoxicity in vitro.
    Baker JR; Gilbert J; Paula S; Zhu X; Sakoff JA; McCluskey A
    ChemMedChem; 2018 Jul; 13(14):1447-1458. PubMed ID: 29771007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A focused library synthesis and cytotoxicity of quinones derived from the natural product bolinaquinone.
    Ghods A; Gilbert J; Baker JR; Russell CC; Sakoff JA; McCluskey A
    R Soc Open Sci; 2018 Apr; 5(4):171189. PubMed ID: 29765626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrimidyn-Based Dynamin Inhibitors as Novel Cytotoxic Agents.
    Odell LR; Chau N; Russell CC; Young KA; Gilbert J; Robinson PJ; Sakoff JA; McCluskey A
    ChemMedChem; 2022 Jan; 17(1):e202100560. PubMed ID: 34590434
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.